MedPath

Ketorolac as an additive to bupivacaine in pectoral nerve block

Phase 3
Conditions
Anaesthesia
Registration Number
PACTR201907766143535
Lead Sponsor
Suez Canal University hospitals
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
46
Inclusion Criteria

•Females aged between 21 – 60 years
•Patients ASA class II (American Society of Anesthesiologists physical status Grade II) = (patients with mild systemic disease and no functional limitations).
•Patients with Body Mass Index (BMI) = 35.

Exclusion Criteria

•Patients with history of bleeding diathesis or on anticoagulant.
•Patients with relevant drug allergy.
•Prior surgery in the supraclavicular, infraclavicularor axillary regions.
•Patients with psychiatric illnesses, opioid dependence; alcohol or drug abuse that would interfere with perception and assessment of pain.
•Patients with any metastasis.
•Deformities of (face, teeth,tongue,palate,mandible,neck) that interfere with airway management.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the first time of analgesic requirement in both groups.;postoperative total dose of analgesic consumption;postoperative hemodynamics and visual analogue score
Secondary Outcome Measures
NameTimeMethod
intra-operative hemodynamics;intraoperative analgesic consumption
© Copyright 2025. All Rights Reserved by MedPath